MedPath

Translumina GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

Recruiting
Conditions
Artery Coronary Stenosis
First Posted Date
2024-05-20
Last Posted Date
2024-06-06
Lead Sponsor
Translumina GmbH
Target Recruit Count
3000
Registration Number
NCT06420505
Locations
🇫🇷

CHU CAEN, Caen, France

🇫🇷

Hôpital A. Schweitzer - GHCA, Colmar, France

🇫🇷

CHU La Timone, Marseille, France

and more 16 locations

Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice

Recruiting
Conditions
Ischemic Heart Disease
First Posted Date
2023-01-30
Last Posted Date
2023-11-27
Lead Sponsor
Translumina GmbH
Target Recruit Count
5000
Registration Number
NCT05703646
Locations
🇦🇪

Al Qassimi hospital, Sharjah, United Arab Emirates

Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems

Active, not recruiting
Conditions
Coronaropathy
First Posted Date
2019-04-17
Last Posted Date
2024-05-08
Lead Sponsor
Translumina GmbH
Target Recruit Count
2722
Registration Number
NCT03918070
Locations
🇫🇷

Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France

🇫🇷

Centre Hospitalier Haguenau, Haguenau, France

🇫🇷

Clinique Saint Hilaire, Rennes, France

and more 16 locations

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

Phase 4
Terminated
Conditions
Coronary Disease
First Posted Date
2005-09-09
Last Posted Date
2020-10-08
Lead Sponsor
Translumina GmbH
Target Recruit Count
333
Registration Number
NCT00152308
Locations
🇦🇹

St. Johanns Spital, Salzburg, Austria

🇦🇹

Allgemeines Krankenhaus Wien, Vienna, Austria

🇩🇪

Deutsches Herzzentrum Muenchen, Munich, Germany

and more 7 locations
© Copyright 2025. All Rights Reserved by MedPath